This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

American Society Of Anesthesiologists Names Manuel E. Bonilla As Chief Advocacy Officer

CHICAGO and WASHINGTON, March 4, 2013 /PRNewswire-USNewswire/ -- The American Society of Anesthesiologists (ASA) today announced the appointment of Manuel E. Bonilla, M.S. as ASA's new chief advocacy officer, centered in the Washington, D.C. office. Since joining the Society in 1997 as a federal affairs coordinator, Manuel has served in various roles, most recently as the Society's director of congressional and political affairs since 2006.

"In his new role, I am confident Manuel will continue to effectively advance ASA's advocacy initiatives and policy agenda in both the public and private sectors," said ASA's Chief Executive Officer Paul Pomerantz. "In his more than 16 years supporting ASA's federal and state legislative and regulatory activities, Manuel has demonstrated exceptional strategic leadership in building relationships with key members of the House and Senate."

As chief advocacy officer, Manuel will develop and implement effective strategies that will maintain the Society's credibility and raise the standards of the medical practice of anesthesiology.

"ASA membership is pleased Manuel will oversee all of ASA's advocacy efforts related to addressing Medicare payment, pain medicine policy, practice parameters for non-physician providers, and a host of other health care policy matters critical to our specialty," said ASA President Dr. John M. Zerwas.

"I am honored to have been selected to provide the vital leadership and vision to help strengthen ASA as the voice of American anesthesiologists," said Mr. Bonilla. "Our work is essential to educating legislators and policymakers on the importance of ensuring the highest quality patient care and safety with physician-led care."

Mr. Bonilla received an M.S. specializing in health care management from Marymount University in Arlington, Va. and a B.A. in Politics from Washington and Lee University in Lexington, Va.

The American Society of Anesthesiologists

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%
YHOO $36.59 -0.97%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs